leisure time -WSS

leisure time

author：focus 2025-10-01 10:59:45 - browse：1

Biotech startup Generate Biomedicines, which uses artificial intelligence to find new drugs, raised $273 million in a Series C funding round from investors including pharma company Amgen and the VC arm of AI giant NVIDIA.

Generate was founded in 2018 by venture-creation firm Flagship Pioneering to use machine learning algorithms to identify antibodies, peptides, cell therapies, and other medicines. It launched its first clinical trial in July for a Covid monoclonal antibody, and is working on starting another clinical trial for an asthma treatment.

The biotech, which is based in Somerville, Mass., has big plans for the next couple of years: It has another 15 drug candidates in the works and plans to introduce 10 more annually, CEO Mike Nally told STAT.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Guidelines to prevent youth baseball injuries need more muscle

WSS

White House drug shortages task force keeps mum with Congress

After John Oliver segment, STAT readers share their opioid

GOP presidential candidates start declaring their loyalty

Medicare proposal to cover medical devices draws a mixed reaction

Presidential candidate assassinated in Ecuador, 1 suspect dead and 6 arrested

Genentech weighs delaying cancer therapy after drug pricing law

knowledge

leisure time

hotspot

State Dept. review finds Biden bears some blame for Afghanistan failures

The high cost of giving birth even with insurance

Heart attack and stroke risk calculators need revising

Cancer drug shortages should be causing more outrage

The cancer drug shortage isn’t new — and neither are the solutions

White House drug shortages task force keeps mum with Congress

Guidelines to prevent youth baseball injuries need more muscle

Walensky prepares to leave CDC — and Congress — behind

Medicare details structure of new drug price negotiation program

Pharma budget tightening trickles down to Doximity

explore

CDC overhauls leadership of center that led response to Covid

Medicare details structure of new drug price negotiation program

Supreme Court strikes down use of affirmative action

TB outbreak tied to bone grafts underscores testing shortcomings

Newly revealed memo details efforts to keep Trump in power following election loss

'Disease catastrophe' looms in Sudan as health conditions deteriorate, medics warn

leisure time

Wikipedia

Wikipedia

entertainment